Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy

An essential step for cancer vaccination is to break the immunosuppression and elicit a tumor-specific immunity. A major hurdle against cancer therapeutic vaccination is the insufficient immune stimulation of the cancer vaccines and lack of a safe and efficient adjuvant for human use. We discovered...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Aihua, Chen, Yingzhi, Wang, Hairui, Chang, Ya, Zhang, Meng, Zhao, Pengfei, Tang, Yisi, Xu, Qin, Zhu, Zhuangzhi, Cao, Yang, Huang, Yongzhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642616/
https://www.ncbi.nlm.nih.gov/pubmed/34900541
http://dx.doi.org/10.1016/j.apsb.2021.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642616/
https://www.ncbi.nlm.nih.gov/pubmed/34900541
http://dx.doi.org/10.1016/j.apsb.2021.06.001

Ejemplares similares